Project Grant HT94252410020
Award Date 1/15/24
Completion Date 1/14/27
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
- The University of Utah has been awarded a $824,512 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from June 1, 2024 to May 31, 2027, will fund research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." This project aims to leverage digital pathology techniques to improve the prediction of treatment outcomes for patients with hormone-sensitive...
- The University of Utah has been awarded a $654,105 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." The three-year grant, awarded on June 1, 2024, will support the university's cutting-edge research aimed at improving health outcomes for military service members, veterans, and the broader public. The...
- The University of Utah will receive $6,079,790 under a four-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2022 to June 2026 to develop functional precision oncology approaches to predict, prevent, and treat early metastatic recurrence of triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
- The University of Utah will receive $1.3 million under a four-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2022 to June 2026 to develop functional precision oncology approaches to predict, prevent, and treat early metastatic recurrence of triple-negative breast cancer. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
- The University of Utah has been awarded a $1,232,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETING IRON-SULFUR CLUSTER ASSEMBLY A NOVEL VULNERABILITY IN KIDNEY CANCER," will fund research focused on developing new treatment approaches for kidney cancer. The award period runs from July 1, 2024, through June 30, 2028. This federal grant program supports a range of biomedical...
- The University of Utah will receive $3.56 million through a four-year cooperative agreement award from the Department of the Army Medical Command under the Military Medical Research and Development program. The university will work to prevent lethal metastatic breast cancer by identifying and eradicating clinically relevant disseminated tumor cells. The award period runs from August 1, 2022 through July 31, 2026 with performance taking place in Salt Lake City, Utah. Through this funding, the...
- This Project Grant award of $1,539,469.00 from the Defense Health Agency was provided to the University of Utah under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Molecular Crosstalk Between Estrogens and Progestogens in Endometrial Cancer." The award will fund this biomedical research project from September 1, 2023 to August 31, 2026. The University of Utah has an extensive track record of collaborating with government agencies on...
- The Defense Health Agency awarded a Project Grant titled "PROGESTIN THERAPY FOR ENDOMETRIAL CANCER" to the University of Utah in the amount of $470,919.00 under the Military Medical Research and Development program (CFDA 12.420). The grant, with a period of performance from August 1, 2023 to July 31, 2027, will fund research to investigate medical solutions for the battlefield, with a focus on transforming healthcare for Service Members and the American public through innovative and...
- This $746,410 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the University of Utah supports research to investigate "Tissue Softening as a Biomarker of Traumatic Brain Injury." The award, effective from August 15, 2024 to August 14, 2027, will enable the university to conduct cutting-edge biomedical research aimed at developing improved diagnostic and treatment approaches for traumatic brain injury, a critical health...
- This federal Project Grant award, valued at $538,998.00 and provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), aims to enhance the antitumor myeloid immune response for the treatment of adrenocortical carcinoma. The award was made to the University of Utah's Office of Sponsored Projects Division, a major recipient of federal funding that conducts cutting-edge biomedical research. The funding will support a research project focused...